高雄長庚紀念醫院解剖病理科

返回首頁 > 醫師介紹

姓名：	黃昭誠(Huang Chao-Cheng)

學歷：	高雄醫學院醫學系畢業

經歷：	2015~迄今長庚大學專任教授 1994~迄今高雄長庚紀念醫院病理科主治醫師 2007~2015 長庚大學專任副教授 2003~2007 長庚大學助理教授 2002~2010 高雄長庚紀念醫院解剖病理科主任 1998~2002 輔英技術學院講師 1998~1999 長庚護專講師 1997~1998 美國約翰霍普金斯大學研究員 1993~1994 高雄長庚紀念醫院病理科住院總醫師 1990~1993 高雄長庚紀念醫院病理科住院醫師

現職：

教授級主治醫師

教職：

長庚大學專任教授

信箱：

研究計畫：

近期研究計畫：

<ol>
	<li>Study on the differential expression of exosomal miRNA between HPV-positive and HPV-negative head and neck squamous cell carcinoma. Chang Gung Medical Research Proposal, CMRPG8G1271 (01/01/2018 - 12/31/2018).</li>
	<li>Evaluation of DLK1 as a prognostic and chemoresistance biomarker of ovarian serous carcinomas. Ministry of Science and Technology Proposal, MOST 107-2320-B-182-037-MY3 (08/01/2018 - 07/31/2021).</li>
	<li>Evaluation of the scoring agreement of immunohistochemistry for Ventana SP263 PD-L1 antibody on non-small cell lung cancer, head and neck squamous cell cancer and urothelial carcinoma, and the comparison of Ventana SP263 PD-L1 antibody and DAKO PharmDx 22C3 PD-L1 antibody on non-small cell lung cancer - International IO Ring Study. Chang Gung Clinical Trial Proposal, XMRPG8H0421 (08/22/2018 - 06/30/2019).</li>
	<li>Delineating the role of Delta-like non-canonical Notch ligand 1 (DLK1) in liver fibrosis. Chang Gung-Zhongshan Conjoint Medical Research Proposal, CMRPG8I0281 (01/01/2019 - 12/31/2019).</li>
</ol>

近期研究計畫：

Study on the differential expression of exosomal miRNA between HPV-positive and HPV-negative head and neck squamous cell carcinoma. Chang Gung Medical Research Proposal, CMRPG8G1271 (01/01/2018 - 12/31/2018).
Evaluation of DLK1 as a prognostic and chemoresistance biomarker of ovarian serous carcinomas. Ministry of Science and Technology Proposal, MOST 107-2320-B-182-037-MY3 (08/01/2018 - 07/31/2021).
Evaluation of the scoring agreement of immunohistochemistry for Ventana SP263 PD-L1 antibody on non-small cell lung cancer, head and neck squamous cell cancer and urothelial carcinoma, and the comparison of Ventana SP263 PD-L1 antibody and DAKO PharmDx 22C3 PD-L1 antibody on non-small cell lung cancer - International IO Ring Study. Chang Gung Clinical Trial Proposal, XMRPG8H0421 (08/22/2018 - 06/30/2019).
Delineating the role of Delta-like non-canonical Notch ligand 1 (DLK1) in liver fibrosis. Chang Gung-Zhongshan Conjoint Medical Research Proposal, CMRPG8I0281 (01/01/2019 - 12/31/2019).

重要著作：

近年重要著作：

<ol>
	<li>Huang CC*, Cheng SH, Wu CH, Li WY, Wang JS, Kung ML, Chu TH, Huang ST, Feng CT, Huang SC, Tai MH*. Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling. Oncogene 2019 April 38:3201-3215.  (SCI) (First author and *co-corresponding author)</li>
	<li>Huang CC*, Kuo HM*, Wu PC, Cheng SH, Chang TT, Chang YC, Kung ML, Wu DC, Chuang JH, Tai MH. Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch 1/Akt/eNOS signaling in endothelial cells. Angiogenesis 2018, 21:299-312   (SCI) (*Co-first author)</li>
	<li>Rau KM, Chen HK, Shiu LY, Chao TL, Lo YP, Wang CC, Lin MC, Huang CC*. Discordance of mutation statuses of epidermal growth factor receptor and K-ras between primary adenocarcinoma of lung and brain metastasis. Int J Mol Sci 2016 Apr;17(4): E524.  (SCI) (Corresponding author)</li>
	<li>Lin LL*, Huang CC*, Wu CL, Wu MT, Hsu WM, Chuang JH. Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts. Lab Invest 2016 May 16 [Epub ahead of print].  (SCI) (*Co-first author)</li>
	<li>Huang CC*, Wang SY*, Lin LL, Wang PW, Chen TY, Hsu WM, Lin TK, Liou CW, Chuang JH. Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth. Dis Model Mech 2015 Oct;8(10):1247-1254.  (SCI) (*Co-first author)</li>
	<li>Huang EY, Chanchien CC, Lin H, Wang CC, Wang CJ, Huang CC*. Galectin-1 is an independent prognostic factor for local recurrence and survival after definitive radiation therapy for patients with squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2013 Dec;87(5):975-982.  (SCI) (Corresponding author)</li>
	<li>Hsu WM*, Huang CC*, Wu PY, Lee H, Huang MC, Tai MH, Chuang JH. Toll-like receptor 3 expression inhibits cell invasion and migration and predicts a favorable prognosis in neuroblastoma. Cancer Lett 2013 Aug;336(2):338-346.  (SCI) (*Co-first author)</li>
	<li>Lu MH*, Huang CC*, Pan MR*, Chen HH, Hung WC. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Clin Cancer Res 2012 Dec;18(23):6416-6425.  (SCI) (*Co-first author)</li>
</ol>

近年重要著作：

Huang CC*, Cheng SH, Wu CH, Li WY, Wang JS, Kung ML, Chu TH, Huang ST, Feng CT, Huang SC, Tai MH*. Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling. Oncogene 2019 April 38:3201-3215. (SCI) (First author and *co-corresponding author)
Huang CC*, Kuo HM*, Wu PC, Cheng SH, Chang TT, Chang YC, Kung ML, Wu DC, Chuang JH, Tai MH. Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch 1/Akt/eNOS signaling in endothelial cells. Angiogenesis 2018, 21:299-312 (SCI) (*Co-first author)
Rau KM, Chen HK, Shiu LY, Chao TL, Lo YP, Wang CC, Lin MC, Huang CC*. Discordance of mutation statuses of epidermal growth factor receptor and K-ras between primary adenocarcinoma of lung and brain metastasis. Int J Mol Sci 2016 Apr;17(4): E524. (SCI) (Corresponding author)
Lin LL*, Huang CC*, Wu CL, Wu MT, Hsu WM, Chuang JH. Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts. Lab Invest 2016 May 16 [Epub ahead of print]. (SCI) (*Co-first author)
Huang CC*, Wang SY*, Lin LL, Wang PW, Chen TY, Hsu WM, Lin TK, Liou CW, Chuang JH. Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth. Dis Model Mech 2015 Oct;8(10):1247-1254. (SCI) (*Co-first author)
Huang EY, Chanchien CC, Lin H, Wang CC, Wang CJ, Huang CC*. Galectin-1 is an independent prognostic factor for local recurrence and survival after definitive radiation therapy for patients with squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2013 Dec;87(5):975-982. (SCI) (Corresponding author)
Hsu WM*, Huang CC*, Wu PY, Lee H, Huang MC, Tai MH, Chuang JH. Toll-like receptor 3 expression inhibits cell invasion and migration and predicts a favorable prognosis in neuroblastoma. Cancer Lett 2013 Aug;336(2):338-346. (SCI) (*Co-first author)
Lu MH*, Huang CC*, Pan MR*, Chen HH, Hung WC. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Clin Cancer Res 2012 Dec;18(23):6416-6425. (SCI) (*Co-first author)

[ 返回上一頁 ]